This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“Lindus breaks the cycle by completely reinventing the way clinical trials operate, allowing lifescience companies to iterate faster.” “We’re fixing that with a new paradigm for running trials underpinned by technology.
” For this report, PwC’s Health Research Institute surveyed 2,511 American consumers, 128 health plan executives, 153 healthcare provider organization executives, and 124 pharmaceutical and lifesciences executives in August and September 2020. ” the report read. “Quite a bit, it turns out.
ONC and the Substance Abuse and Mental Health Services Administration (SAMHSA) are launching a $20 million Behavioral Health Information Technology Initiative to improve IT adoption in psychiatry and behavioral health. Lifesciences data vendor H1 released GenosAI Pro , which brings conversational AI to feasibility planning and trial design.
Twill and e-Psychiatry are working together to increase access to psychiatrists, psychologists, and therapists for high-acuity patients. Twilio launched a version of Segment , its Customer Data Platform, for healthcare and lifesciences.
In addition, biopharma, medical devices, and other lifesciences companies accelerate the high competition among CME providers. continuing medical education market is expected to reach a value of $4.23 billion by 2028 from $2.91 billion in 2022, growing at a CAGR of 6.43% The U.S.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content